ASPiRATION An observational cohort study to assess the clinical impact of comprehensive genomic profiling in metastatic lung cancer patients Challenge Lung cancer is the leading cause of cancer death in Australia and worldwide, with a five-year survival rate of only 17 per cent. Study The ASPiRATION program is a pioneering partnership between government, industry and […]